Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Prevest DenproBOM:543363 +0.78%84 PEG Ratio is 1.40 as of Jul. 25, 2026, which is 1% below its 10-year median of 1.41. GuruFocus rates BOM:543363 with a GF Score™ of 84/100 and a GF Value™ of ₹622.13 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 207 Medical Devices & Instruments companies, Prevest Denpro ranks better than 61.84% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Prevest Denpro's PEG Ratio or its related term are showing as below:
BOM:543363'
s PEG Ratio Range Over the Past 10 Years
Min: 0.91 Med: 1.41 Max: 1.62
Current: 1.4
During the past 8 years, Prevest Denpro's highest PEG Ratio was 1.62. The lowest was 0.91. And the median was 1.41.
BOM:543363's PEG Ratio is ranked better than 61.84% of 207
companies
in the Medical Devices & Instruments industry
Industry Median: 1.89
vs BOM:543363: 1.40
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Prevest Denpro (BOM:543363) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Prevest Denpro PEG Ratio Related Terms
Prevest Denpro PEG Ratio Historical Data
* Premium members only.
The historical data trend for Prevest Denpro's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543363 vs ISRG, BDX, MDLN: PEG Ratio Comparison
For the Medical Instruments & Supplies subindustry, Prevest Denpro's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prevest Denpro PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Prevest Denpro's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Prevest Denpro's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Prevest Denpro (BOM:543363) has a PEG Ratio of 1.40 as of Jul. 25, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Prevest Denpro and its competitors. This is near median its historical median of 1.41. Over the past decade, Prevest Denpro's PEG Ratio has ranged from 0.91 to 1.62. According to the industry distribution chart, Prevest Denpro ranks #79 out of 207 companies in the Medical Devices & Instruments industry, placing it in the top 38.2%.
Is Prevest Denpro's PEG Ratio too high?
Prevest Denpro's current PEG Ratio of 1.40 is near median its 10-year median of 1.41. Over the past 10 years, this metric has ranged from a low of 0.91 to a high of 1.62. The Medical Devices & Instruments industry median PEG Ratio is 1.89. Prevest Denpro's value of 1.40 is 25.9% below this industry median. Based on the distribution chart, Prevest Denpro ranks #79 out of 207 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Prevest Denpro has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Prevest Denpro's PEG Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Prevest Denpro ranks #79 out of 207 companies for PEG Ratio. This puts Prevest Denpro in the upper half of its industry. The industry median PEG Ratio is 1.89. Prevest Denpro's value of 1.40 is 25.9% below this benchmark. Historically, Prevest Denpro's own PEG Ratio has ranged from 0.91 to 1.62 over the past decade. While the company's 10-year median is 1.41 vs. the industry median of 1.89, Prevest Denpro has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 1.89, based on 207 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Prevest Denpro's current PEG Ratio of 1.40 is 25.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Prevest Denpro and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 1.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Prevest Denpro's current PEG Ratio is 1.40, which is near median its own 10-year median of 1.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prevest Denpro stock overvalued right now?
Based on GuruFocus' analysis, Prevest Denpro (BOM:543363) is currently considered Possible Value Trap. The stock's GF Value™ is ₹622.13, compared to a current price of ₹390.00 — trading 37.3% below its estimated fair value. The current PEG Ratio is 1.40, which is near median its 10-year median of 1.41 and 25.9% below the Medical Devices & Instruments industry median of 1.89. Prevest Denpro's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Prevest Denpro (BOM:543363), the current PEG Ratio is 1.40 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Prevest Denpro (BOM:543363) Overvalued in 2026?
Based on GuruFocus' analysis, Prevest Denpro stock appears to be undervalued.
The current stock price of ₹390.00 is trading 37.3% below its estimated GF Value™ of ₹622.13.
GuruFocus considers Prevest Denpro to be Possible Value Trap.
Key valuation signals for BOM:543363:
PEG Ratio: 1.40 (near median its 10-year median of 1.41)
GF Value™: ₹622.13 vs. price of ₹390.00 (37.3% below fair value)
Industry Position: 25.9% below the Medical Devices & Instruments median (#79 of 207)
No single metric tells the full story. See the BOM:543363 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Prevest Denpro Ltd develops, manufactures and markets a comprehensive portfolio of dental materials for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile. The company's product portfolio covers wide spectrum of materials for endodontics, prosthodontics, orthodontics, periodontics, restorative dentistry, aesthetic dentistry and laboratory consumables.
84GF Score
Get the complete analysis for BOM:543363
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543363 has been successfully added to your 
